Efficient Advisors LLC acquired a new stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,476 shares of the company's stock, valued at approximately $892,000.
Other large investors also recently modified their holdings of the company. Bellwether Advisors LLC acquired a new stake in shares of Cardinal Health during the fourth quarter worth $32,000. Tompkins Financial Corp raised its stake in Cardinal Health by 106.7% in the first quarter. Tompkins Financial Corp now owns 248 shares of the company's stock valued at $34,000 after purchasing an additional 128 shares in the last quarter. Itau Unibanco Holding S.A. acquired a new stake in Cardinal Health during the fourth quarter worth about $36,000. GW&K Investment Management LLC grew its stake in Cardinal Health by 113.4% during the first quarter. GW&K Investment Management LLC now owns 271 shares of the company's stock worth $37,000 after buying an additional 144 shares in the last quarter. Finally, Measured Risk Portfolios Inc. acquired a new stake in Cardinal Health during the fourth quarter worth about $47,000. 87.17% of the stock is owned by institutional investors.
Cardinal Health Price Performance
Shares of NYSE:CAH traded down $0.91 during mid-day trading on Friday, hitting $157.37. The company had a trading volume of 650,441 shares, compared to its average volume of 2,395,557. The firm has a fifty day moving average price of $159.37 and a 200 day moving average price of $141.27. Cardinal Health, Inc. has a one year low of $96.05 and a one year high of $168.44. The company has a market capitalization of $37.56 billion, a PE ratio of 24.55, a price-to-earnings-growth ratio of 1.56 and a beta of 0.68.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.15 by $0.20. Cardinal Health had a net margin of 0.70% and a negative return on equity of 68.84%. The business had revenue of $54.88 billion during the quarter, compared to the consensus estimate of $55.33 billion. During the same quarter last year, the firm posted $2.08 EPS. Cardinal Health's revenue was up .0% compared to the same quarter last year. Research analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st were given a $0.5107 dividend. The ex-dividend date was Tuesday, July 1st. This represents a $2.04 annualized dividend and a yield of 1.30%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is presently 31.83%.
Analyst Upgrades and Downgrades
A number of equities research analysts have issued reports on the stock. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Morgan Stanley boosted their target price on shares of Cardinal Health from $181.00 to $190.00 and gave the stock an "overweight" rating in a research note on Wednesday, July 16th. UBS Group boosted their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a "buy" rating in a research note on Tuesday, April 29th. Citigroup reaffirmed a "neutral" rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Finally, Mizuho lifted their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a research report on Monday, March 31st. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $158.07.
Read Our Latest Stock Analysis on CAH
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
